Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population
NCT07211204 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2026-03-03
Summary
This study compares the efficacy of cytology (Pap smear) with the molecular screening in their ability to detect reactive cellular changes in the cervix among an open population
Conditions
- Atypical Squamous Cell of Undetermined Significance
- ASC-US
- Atypical Glandular Cells of Uncertain Significance
- AGUS
- Cervical Intraepithelial Neoplasia (CIN)
- CIN 1
- CIN 2
- CIN 3
- Cervical Cancer
Interventions
- PROCEDURE
-
Physical examination
Physical examination and interview for obtaining a medical record
- OTHER
-
Liquid-based cytology
Screening test for cervical precursor lesions and/or cancer. LBC is a procedure in which a cervical smear is examined under the microscope.
- OTHER
-
Molecular screening
The molecular screening detects three human biomarkers associated with cervical precursor lesions and/or cervical cancer. Biomarker detection is done by Western blot and ELISA in human sera.
- OTHER
-
HPV DNA test
HPV DNA detection is performed using a cervical swab.
- DIAGNOSTIC_TEST
-
Colposcopy
A diagnostic procedure to visually examine the cervix, vagina, and vulva with a colposcope.
- DIAGNOSTIC_TEST
-
Histopathology
Is the definitive diagnosis of cervical precursor lesions and cervical cancer. It is the microscopic study of diseased cells and tissues stained with hematoxylin and eosin.
Sponsors & Collaborators
-
Timser SAPI de CV
lead INDUSTRY
Principal Investigators
-
Leopoldo E Gatica-Galina, MD in OB/GY & Gynecol Oncol · Clinica Reina Madre Metepec
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SCREENING
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-02-27
- Primary Completion
- 2026-02-27
- Completion
- 2026-02-27
Countries
- Mexico
Study Locations
More Related Trials
-
chemQbiosciences:Manual Liquid Based Cytology
NCT01837303 ·Status: COMPLETED
-
Cervical Cytology DNA Methylation for Cervical Cancer Screening
NCT06557954 ·Status: NOT_YET_RECRUITING
-
Gynaecological Follow-up of a Subset of 580299/008 (NCT00122681) Study Subjects
NCT00937950 ·Status: COMPLETED ·Phase: PHASE3
-
DNA Methylation for Screening Uterine Cervical Lesions
NCT03960879 ·Status: UNKNOWN
-
Clinical Studies of Endometrial Cytology and Cervical Methylation Assays in Endometrial Cancer Screening and Fertility-Preservation Evaluation
NCT06672341 ·Status: NOT_YET_RECRUITING
-
Detection of Biomarkers in Abnormal Cervical Cells in Women With Abnormal Pap Test Results
NCT00004091 ·Status: COMPLETED
-
Home-Based or Clinic-Based Human Papillomavirus (HPV) Screening
NCT01550783 ·Status: COMPLETED ·Phase: NA
-
iMproving thE DIagnostics And Treatment Of ceRvical Precancer
NCT05870787 ·Status: COMPLETED
-
Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix
NCT04072913 ·Status: COMPLETED ·Phase: NA
-
Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer
NCT01221987 ·Status: COMPLETED
-
APTIMA HPV 16 18/45 Genotype Assay on the TIGRIS DTS System in Women With ASC-US or Negative Pap Test Results
NCT01384370 ·Status: COMPLETED
-
Genotypification and Predisposing Factors in Human Papilloma Virus Infection
NCT01924117 ·Status: COMPLETED ·Phase: NA
-
Cervical Cancer Screening Strategies
NCT05309122 ·Status: UNKNOWN
-
DNA Methylation for Screening Uterine Cervical Lesions: A Case-control Study
NCT03961191 ·Status: UNKNOWN
-
Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects
NCT01190176 ·Status: COMPLETED ·Phase: PHASE3
-
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2
NCT01837693 ·Status: COMPLETED ·Phase: NA
-
Comparison of Screening Tests in Detecting Cervical Neoplasia
NCT00039312 ·Status: COMPLETED ·Phase: NA
-
Predicting Treatment Failure in HSIL Patients with Positive Margins After Conization Via Detection of PAX1 Methylation
NCT06713655 ·Status: NOT_YET_RECRUITING
-
Application of Plasma Circulating HPV DNA Testing to Management of Cervical Intraepithelial Neoplasia
NCT04274465 ·Status: COMPLETED
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
NCT06498661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
NCT06291311 ·Status: RECRUITING
-
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.
NCT00877877 ·Status: COMPLETED ·Phase: PHASE3
-
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
NCT06002126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Cervical Intraepithelial Neoplasia Screening Using Liquid-Based Pap Smear Among Egyptian Women
NCT07250841 ·Status: COMPLETED
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03)
NCT06611540 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA